Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
82°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Goodrx Holdings Inc Cl A
(NQ:
GDRX
)
8.230
+0.670 (+8.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Goodrx Holdings Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
Next >
GoodRx Holdings Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
August 16, 2024
Via
Benzinga
GoodRx (GDRX) Q2 2024 Earnings Call Transcript
August 08, 2024
GDRX earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription Challenges
August 08, 2024
GoodRx reported Q2 revenue of $200.61M, a 6% YoY increase. Prescription transactions revenue rose 7%, driven by 8% growth in Monthly Active Consumers. The company expects FY 2024 revenue at the lower...
Via
Benzinga
MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday
July 15, 2024
Via
Benzinga
3 Lawsuit-Laden Stocks to Dump Before Problems Multiply
July 10, 2024
These stocks to sell face ongoing and past litigation, but that isn't the only sticking point in their long-term prospects.
Via
InvestorPlace
The Analyst Landscape: 7 Takes On GoodRx Holdings
June 10, 2024
Via
Benzinga
Forecasting The Future: 13 Analyst Projections For GoodRx Holdings
May 16, 2024
Via
Benzinga
Why GoodRx Surged Today
March 25, 2024
The prescription-drug upstart got an upgrade from Wall Street.
Via
The Motley Fool
Market Correction Alert: Sell These 3 Tech Stocks While You Can
June 28, 2024
These tech stocks to sell combine shaky operational outlooks with underlying fundamental shakiness that don't bode well for the long-term.
Via
InvestorPlace
3 Stocks to Sell ASAP Before the June 27 Presidential Debate
June 17, 2024
These stocks to sell sit within politically sensitive sectors, making them too risky to hold as we approach election season.
Via
InvestorPlace
The 3 Most Undervalued Under-$10 Stocks to Buy in June 2024
June 04, 2024
These three, sub $10 stocks with enormous upside potential might just be your best investment nuggets this month.
Via
InvestorPlace
GoodRx Strengthens Core Business With New Initiatives, Analyst Upgrades On Potential Opportunities
May 23, 2024
GoodRx has been upgraded by RBC Capital Markets due to the growth potential from the Integrated Savings Program, direct contracting initiatives, and manufacturing solutions expansion.
Via
Benzinga
GoodRx Shares Soar Nearly 10% As New Partnership With Kroger Promises Big Savings
May 15, 2024
GoodRX shares surged nearly 10% Wednesday afternoon following the announcement of a new direct contracting agreement with Kroger Co. (NYSE:KR).
Via
Benzinga
The Latest Analyst Ratings For GoodRx Holdings
March 25, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
In-Depth Examination Of 4 Analyst Recommendations For GoodRx Holdings
February 26, 2024
Via
Benzinga
NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
May 15, 2024
Via
Benzinga
GoodRx (GDRX) Q1 2024 Earnings Call Transcript
May 09, 2024
GDRX earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Change Healthcare Cyberattack: GoodRx Expects Low Single Digit Million-Dollar Impact In 2024
May 09, 2024
GoodRx's Q1 earnings: $0.08 EPS, sales hit $197.88 million, beating expectations fueled by prescription transactions and pharma solutions. Q2 forecast: ~$200 million revenue, optimistic 2024 outlook.
Via
Benzinga
GDRX Stock Earnings: GoodRx Holdings Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
GDRX stock results show that GoodRx Holdings beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings
April 10, 2024
GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst.
Via
Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Via
Benzinga
Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says
March 25, 2024
Wells Fargo's upgrade of GoodRx Holdings. Analysts anticipate strong revenue visibility and EBITDA margins, setting the stage for potential stock outperformance in 2024-2025.
Via
Benzinga
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
March 25, 2024
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
These Analysts Increase Their Forecasts On GoodRx Following Q4 Earnings
March 01, 2024
GoodRx Holdings, Inc. (NASDAQ: GDRX) reported upbeat fourth-quarter FY23 results and issued first-quarter revenue guidance above estimates.
Via
Benzinga
Why GoodRx Stock Soared Today
February 29, 2024
The company beat Q4 estimates, announced a new share repurchase authorization, and issued strong guidance.
Via
The Motley Fool
GoodRx (GDRX) Q4 2023 Earnings Call Transcript
February 29, 2024
GDRX earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Is Telemedicine Firm GoodRx's Shares Surging Today
February 29, 2024
GoodRx Holdings reported strong Q4 results and issued above-estimate revenue guidance for FY24. Revenue and adjusted EBITDA increased, company also announced new stock repurchase program.
Via
Benzinga
Prescription Drug Discount Provider GoodRx Expects To Build Momentum In 2024, Stock Soars
January 10, 2024
GoodRx Holdings Inc (NASDAQ: GDRX) provided preliminary Q4 FY23 revenue of $195 million-$197 million, up 6%-7% Y/Y, versus the consensus of $190.77 million.
Via
Benzinga
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 10, 2024
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.